The food biotechnology market is projected to grow substantially over the next decade, rising from an estimated USD 32.5 ...

The Fugaku supercomputer builds a highly detailed virtual mouse cortex with millions of neurons enabling unprecedented ...

Diabetic foot ulcer is one of the serious complications which puts the health and the lives of those affected at great risk ...

After devastating losses in the recent banana harvest, onions become the second major crop in the country to succumb to ...

Korro Bio saw its stock reach all-time lows on disappointing data for its lead pipeline candidate, while Intellia Therapeutics saw analyst downgrades on safety concerns despite releasing positive data ...

DENVER, Nov. 17, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market ...

Scribe Therapeutics Inc. ("Scribe"), a genetic medicines company pioneering next-generation in vivo CRISPR-based medicines designed to be safe, durable, and effective enough to become standard-of-care ...

Imagine being a civic leader dealing with the unimaginable – an Ebola or a Zika outbreak threatening the lives of your ...

Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other ...

Sam Altman's support for a gene-editing project aiming to create disease-free babies raises urgent ethical, scientific, and ...

Overview of Autologous Cell Therapy Product MarketGlobal Cell Therapy Market is valued at USD 10.1 Billion in 2025 and is projected to attain a value of USD 16.1 Billion by 2030 at a CAGR of 12.10% ...

Profluent Bio announced a research collaboration with the Rett Syndrome Research Trust (RSRT) to design novel base editors to permanently correct inherited mutations that lead to Rett syndrome, a rare ...